| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.18 | 0.3 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |